| ||
| ||
| ||
New report shows major increase in pharmaceutical R&D for neglected diseases The Pharma Letter R&D, health system capacity-strengthening efforts, and medicine donations comprise the pharmaceutical industry's holistic approach to addressing neglected diseases, according to a new report released yesterday by the International Federation of ... See all stories on this topic » | ||
Jefferies Top Global Pharmaceutical Stock Picks for 2013 (JEF, ABBV, NVS ... 24/7 Wall St. After a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF) predict that 2013 could show more of the same. However they are careful to point out that the odds that the sector will ... See all stories on this topic » | ||
Collegium Pharmaceutical Announces Relocation to Massachusetts International Business Times (press release) 17, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the relocation of its corporate offices and laboratory facilities to ... See all stories on this topic » | ||
| ||
UK's value-based pricing system plans lack clarity, MPs find The Pharma Letter They argue that there should be both a professional and legal obligation to ensure that all regulators, including the NICE, have access to all available research data about the efficacy and safety of pharmaceutical products which are in use in the UK. See all stories on this topic » | ||
Medicago Signs 15 Million Non-Dilutive Loan Agreement with a Major ... MENAFN.COM Medicago Inc. (otcqx:MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announcedtheexecution of15,000,000 ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment